Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid‐induced osteonecrosis in a rabbit model
Authors:
Open Access
- 4 September 2007
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 26 (1) , 91-95
Abstract
Low hepatic cytochrome P4503A (CYP3A) activities might play an important role for inducing osteonecrosis of the femoral head (ONFH) by corticosteroids. However, the relationship between hepatic CYP3A activity and steroid‐induced ONFH is unknown. We have examined the relationship between hepatic CYP3A activity and the inducibility of ONFH in a rabbit model. Sixty rabbits were divided into three groups. Hepatic CYP3A inducer (phenobarbital, group P; n = 15), inhibitor (itraconazole, group I; n = 15), or saline (group C, n = 30) was administrated for 3 weeks before intramuscular methylprednisolone. In groups P and I, hepatic CYP3A levels were measured by midazolam clearance before treatment (baseline) and before methylprednisolone injection. All animals were sacrificed 3 weeks after methylprednisolone injection and both femurs were harvested and examined histologically for osteonecrosis. Midazolam clearance was significantly increased and decreased, compared with baseline in groups P and I respectively (p < 0.0005, p < 0.002). The incidence of osteonecrosis in group P (33%) was significantly lower than in group I (100%) and group C (83%; p < 0.001 for both). The percentage necrotic area to whole bone marrow area on cross sections in group P (8.2 ± 5.9%) was significantly lower than in group I (69.8 ± 20.8%) and group C (51.5 ± 30.7%; p < 0.005 for both). Hepatic CYP3A activity inversely correlated with the incidence of osteonecrosis and extent of the necrotic area caused by the same dose of corticosteroids, suggesting possible prevention of the steroid‐induced osteonecrosis by reducing steroid dose in poor corticosteroid metabolizers. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:91–95, 2008Keywords
This publication has 19 references indexed in Scilit:
- Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosisClinical Pharmacology & Therapeutics, 2006
- The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effectClinical Pharmacology & Therapeutics, 2000
- Effects of the Antifungal Agents on Oxidative Drug MetabolismClinical Pharmacokinetics, 2000
- Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole*Clinical Pharmacology & Therapeutics, 1998
- Non-traumatic avascular necrosis of the femoral head.Journal of Bone and Joint Surgery, 1995
- Association of Alcohol Intake, Cigarette Smoking, and Occupational Status with the Risk of Idiopathic Osteonecrosis of the Femoral HeadAmerican Journal of Epidemiology, 1993
- Induction of various cytochromes CYP2B, CYP2C and CYP3A by phenobarbitone in non-human primatesPharmacogenetics, 1992
- Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjectsBiochemical Pharmacology, 1988
- Early treatment of avascular necrosis in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1986
- Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosusThe American Journal of Medicine, 1985